收藏切换
Trilaciclib combined with immunotherapy and chemotherapy for treatment of advanced esophageal cancer: a case report and literature review
收藏切换
PDF
Jing-ze YAN, Hui CHEN, Xiao-lin GE, Xiao-jie XIA
Chinese Journal of New Drugs | 2023, 32(23) : 2370 - 2374
Less
收藏切换
Chinese Journal of New Drugs | 2023, 32(23): 2370-2374
Trilaciclib combined with immunotherapy and chemotherapy for treatment of advanced esophageal cancer: a case report and literature review
Full
Jing-ze YAN, Hui CHEN, Xiao-lin GE, Xiao-jie XIA
Affiliations
  • Department of Radiation Oncology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing 232100, China
Published: 2023-12-15
Outline
收藏切换

Immunotherapy combined with chemotherapy has been established as the standard first-line treatment in advanced esophageal cancer (EC). Myelosuppression is the most common side effects of chemotherapy, and severe myelosuppression often leads to prolonged cycles of chemotherapy and reduced doses of chemotherapy, thereby reducing the intensity and potential anti-tumor efficacy of chemotherapy. At present, granulocyte-stimulating factor (G-CSF) is widely used to stimulate the differentiation of bone marrow hematopoietic progenitor cells to treat chemotherapy-induced myelosuppression (CIM). Trilaciclib is a short-acting and reversible CDK4/6 inhibitor, which can provide systemic protection of bone marrow hematopoiesis, and was approved by NMPA in July 2022 for the prophylactic treatment of myelosuppression in extensive-stage small cell lung cancer (ES-SCLC). However, trilaciclib has not been widely used in clinical practice. Therefore, this paper reports a case of one patient with advanced EC who was treated by trilaciclib to prevent CIM in our department, aiming to provide further reference and basis for further investigation.

esophageal cancer  /  chemotherapy  /  trilaciclib  /  myelosuppression  /  bone marrow protection
Jing-ze YAN, Hui CHEN, Xiao-lin GE, Xiao-jie XIA. Trilaciclib combined with immunotherapy and chemotherapy for treatment of advanced esophageal cancer: a case report and literature review[J]. Chinese Journal of New Drugs, 2023 , 32 (23) : 2370 -2374 .
Year 2023 volume 32 Issue 23
PDF
41
13
Cite this Article
BibTeX
Article Info
  • Online Date:2026-03-05
  • Published:2023-12-15
Article Data
Affiliations
History
  • Accepted:2023-09-20
Affiliations
    Department of Radiation Oncology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing 232100, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT